Cargando…
Integrative Analysis Reveals Potentially Functional N6-Methylandenosine-Related Long Noncoding RNAs in Colon Adenocarcinoma
N6-methyladenosine (m6A) is one of the most prevalent RNA modifications in mRNA and non-coding RNA. In this study, we identified 10 upregulated m6A regulators at both mRNA and protein levels, and 2,479 m6A-related lncRNAs. Moreover, the m6A-related long noncoding RNAs (lncRNAs) could clearly stratif...
Autores principales: | Tan, Xinjie, Li, Qian, Zhang, Qinya, Fan, Gang, Liu, Zhuo, Zhou, Kunyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484874/ https://www.ncbi.nlm.nih.gov/pubmed/34603397 http://dx.doi.org/10.3389/fgene.2021.739344 |
Ejemplares similares
-
Constructing a novel signature and predicting the immune landscape of colon cancer using N6-methylandenosine-related lncRNAs
por: Wang, Yongfeng, et al.
Publicado: (2023) -
Identification of Prognostic Markers of N6-Methylandenosine-Related Noncoding RNAs in Non-Small-Cell Lung Cancer
por: Zhang, Zexin, et al.
Publicado: (2022) -
Identification of N6-Methylandenosine-Related lncRNAs for Subtype Identification and Risk Stratification in Gastric Adenocarcinoma
por: Huang, Yuancheng, et al.
Publicado: (2021) -
N6-Methylandenosine-Related lncRNAs in Tumor Microenvironment Are Potential Prognostic Biomarkers in Colon Cancer
por: Zhang, Hongliang, et al.
Publicado: (2021) -
Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients
por: Li, Zhiyong, et al.
Publicado: (2022)